Statistics for S.I.I.T. srl

329Total Devices

329Basic UDI-DIs

0Not destined for EU market

1Certificates

1Valid

0Expiring < 6 months

24Countries

Certificate health for S.I.I.T. srl

Devices by risk class

Device catalog for S.I.I.T. srl

Showing 326–329 of 329 devices.

Trade name	Reference / catalog number	UDI-DI code	Quantity	Status
OC14	`OC14`	`D-060079298A`	1	On the market
GC07A (mango)	`GC07A (mango)`	`D-0600635678`	1	On the market
GC09	`GC09`	`D-060060096G`	1	On the market
GC06	`GC06`	`D-0600884182`	1	On the market

10 11 12 13 14

Device families (Basic UDI-DI) of S.I.I.T. srl

Showing 26–50 of 65 device families.

1 2 3

Market presence of S.I.I.T. srl

Devices placed in 24 countries

Italy129
Poland31
Germany24
Spain20
EL15
France15
Belgium13
Croatia13
Austria10
Czechia10
Bulgaria8
Finland7
Portugal7
Romania7
Denmark3
Ireland3
Netherlands3
Sweden3
Hungary2
Latvia2
Cyprus1
Estonia1
Luxembourg1
Slovenia1

EUDAMED update: Mar 13, 2026

S.I.I.T. srl

IT-MF-000022188

Active

Address: Via Ariosto, 50/60 20090 Trezzano sul Naviglio (Milan)
Role: Manufacturer
Date of registration: Mar 30, 2022
Country: IT Italy

About S.I.I.T. srl

SRN: IT-MF-000022188
Role: Manufacturer
Country: Italy
Organization name: S.I.I.T. srl
EU VAT number: IT00820090157
Date of registration: Mar 30, 2022

Contact details for S.I.I.T. srl

Address: 50/60, VIA ARIOSTO 20090 TREZZANO SUL NAVIGLIO (MILAN) ITALY
Phone: +02 4843521
Email: surveillance@siit-it.com
Website: www.siitgroup.com

Validator

Name: Ministero della salute - Direzione generale dei dispositivi medici e del servizio farmaceutico
SRN: IT-CA-070
Phone: +39 06 5994 3199/ +39 06 5994 3207
Email: segr.dgfdm@sanita.it

Officers and regulatory representatives of S.I.I.T. srl

PRAMPOLINI Simona
(a) the conformity of the devices is appropriately checked, in accordance with the quality management system under which the devices are manufactured, before a device is released;
Hidden
COSTA Andrea Domizio
(b) the technical documentation and the EU declaration of conformity are drawn up and kept up-to-date; (c) the post-market surveillance obligations are complied with in accordance with Article 10(10); (d) the reporting obligations referred to in Articles 87 to 91 are fulfilled; (e) in the case of investigational devices, the statement referred to in Section 4.1 of Chapter II of Annex XV is issued.
Hidden

Become a partner of MD Atlas